{"id":48,"date":"2019-09-09T18:51:17","date_gmt":"2019-09-10T01:51:17","guid":{"rendered":"http:\/\/cloudbreakther.wpengine.com\/?page_id=48"},"modified":"2026-06-05T12:21:11","modified_gmt":"2026-06-05T19:21:11","slug":"pipeline","status":"publish","type":"page","link":"https:\/\/cloudbreakpharma.com\/zh_hk\/pipeline\/","title":{"rendered":"\u7522\u54c1\u7ba1\u7dda"},"content":{"rendered":"<div data-elementor-type=\"wp-page\" data-elementor-id=\"48\" class=\"elementor elementor-48\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-aa88315 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"aa88315\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t\t<div class=\"elementor-background-overlay\"><\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-a569796\" data-id=\"a569796\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-7d5f48e elementor-widget elementor-widget-heading\" data-id=\"7d5f48e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">\u591a\u9805\u5c08\u5229\u6388\u6b0a\u53ca\u773c\u79d1\u5019\u9078\u85e5\u7269\u7ba1\u7dda<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-deb556e elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"deb556e\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-b9aa902\" data-id=\"b9aa902\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-87d1bdc elementor-widget elementor-widget-text-editor\" data-id=\"87d1bdc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>We are advancing wholly-owned ophthalmic drug pipeline candidates that address a number of diseases with high unmet need, from front-of-eye conditions to back-of-eye conditions. The lead project is CBT-001 for the treatment of pterygium.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-c81b4fe elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"c81b4fe\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-0f40fb9\" data-id=\"0f40fb9\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3a33a14 elementor-widget__width-initial elementor-widget elementor-widget-image\" data-id=\"3a33a14\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"2531\" height=\"1107\" src=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/03\/Cloudbreak-Pipeline-March-25-2026.png\" class=\"attachment-full size-full wp-image-1361\" alt=\"\" srcset=\"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/03\/Cloudbreak-Pipeline-March-25-2026.png 2531w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/03\/Cloudbreak-Pipeline-March-25-2026-300x131.png 300w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/03\/Cloudbreak-Pipeline-March-25-2026-1024x448.png 1024w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/03\/Cloudbreak-Pipeline-March-25-2026-768x336.png 768w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/03\/Cloudbreak-Pipeline-March-25-2026-1536x672.png 1536w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/03\/Cloudbreak-Pipeline-March-25-2026-2048x896.png 2048w, https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2026\/03\/Cloudbreak-Pipeline-March-25-2026-18x8.png 18w\" sizes=\"(max-width: 2531px) 100vw, 2531px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Multiple Patents Granted and Pipeline of Ophthalmic Drug Candidates We are advancing wholly-owned ophthalmic drug pipeline candidates that address a number of diseases with high unmet need, from front-of-eye conditions to back-of-eye conditions. The lead project is CBT-001 for the treatment of pterygium.<\/p>","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-48","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/pages\/48","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/comments?post=48"}],"version-history":[{"count":0,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/pages\/48\/revisions"}],"wp:attachment":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/media?parent=48"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}